Britney Spears mother Lynne begging star to leave LA and live with ... - Yahoo Finance UK

RAFA Stock  USD 0.09  0.03  47.54%   
About 55% of Rafarma Pharmaceuticals' investors are presently thinking to get in. The analysis of overall sentiment of trading Rafarma Pharmaceuticals pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Rafarma Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Rafarma Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Britney Spears mother Lynne begging star to leave LA and live with ... Yahoo Finance UK

Read at news.google.com
Google News at Macroaxis
  

Rafarma Pharmaceuticals Fundamental Analysis

We analyze Rafarma Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rafarma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rafarma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Rafarma Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Peers

Trending Equities

INTC  2.41   
0%
42.0%
WFC  2.19   
0%
39.0%
S  1.25   
0%
22.0%
BBY  1.10   
0%
19.0%
C  0.68   
0%
12.0%
AAPL  0.07   
0%
1.0%
UPS  0.16   
2.0%
0%
MET  0.30   
5.0%
0%
IBM  0.65   
11.0%
0%
AA  1.26   
22.0%
0%
HD  1.50   
26.0%
0%
TGT  1.54   
27.0%
0%
AAL  2.36   
42.0%
0%
CVX  2.93   
52.0%
0%
T  3.34   
59.0%
0%
CVS  5.61   
100.0%
0%

Complementary Tools for Rafarma Pink Sheet analysis

When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine